Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

4 Insurance Stocks to Sell Now

The ratings of four insurance stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

9 Biotechnology Stocks to Sell Now

This week, the ratings of nine biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Semiconductor Stocks to Sell Now

The overall ratings of six semiconductor stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Medical Technology Stocks to Sell Now

This week, the overall grades of three medical technology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Service Stocks to Sell Now

This week, the ratings of four service stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Ugly Earnings Momentum — FNBN GYRO APU SGY HXM

This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

Why YELP Stock Is Overvalued

YELP stock won't be able to maintain the growth rates necessary to justify analysts' target prices, which range between $65 and $75 a share.

5 Worst Sectors to Avoid This Week

According to the Portfolio Grader database this week, the energy services, marine, construction and engineering, electrical equipment and distributors sectors are at the bottom.

Aeropostale Earnings Preview: More Misery for Teen Retailers?

The Aeropostale earnings report slated for Thursday may pop the small bubble that's pushed ARO higher since mid-February.

Antibiotic-Free Chicken and Kale Aren’t Game-Changers for MCD

Investors who own MCD stock have little to be excited about, despite the healthier menu. McDonald's problems go much deeper.

Twitter (TWTR) Stock: Still Dead Money Despite JPM Optimism

Twitter (TWTR) stock rose on Monday after a bullish report from JPMorgan put a price target of $67 on shares. That's never going to happen.

5 Stocks With Awful Cash Flow — HXM TWGP HELI STP ATPG

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

Sell Kythera (KYTH) Stock, Another Biotech Ripoff

Don't let high-flying biotech Kythera Biopharmaceuticals Inc (KYTH) tempt you; it's primed for a gnarly selloff.

YHOO: Without Alibaba, There’s Not Much to Like About Yahoo Stock

Yahoo stock has been feeding off Alibaba for too long. Once its holdings are spun off, YHOO will look pretty lean.

3 Media Stocks to Sell Now

The overall ratings of three media stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Tech Services Stocks to Sell Now

This week, the overall grades of three tech services stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

12 Metals and Mining Stocks to Sell Now

For the current week, the overall ratings of 12 metals and mining stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Medical Devices Stocks to Sell Now

The ratings of three medical devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Blue Chips Teetering Over the Brink

Friday's jobs report sparked fears that we'll see an interest-rate hike sooner than later and sent these five blue chips into new downtrends.